Product References
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies.
Communications medicine
Kongsuphol P,Jia H,Cheng HL,Gu Y,Shunmuganathan BD,Chen MW,Lim SM,Ng SY,Tambyah PA,Nasir H,Gao X,Tay D,Kim S,Gupta R,Qian X,Kozma MM,Purushotorman K,McBee ME,MacAry PA,Sikes HD,Preiser PR
MA5-29975 was used in Enzyme-linked immunosorbent assay to report a rapid cellulose pull-down viral neutralization test (cpVNT) that detects SARS-CoV-2 NAbs in plasma samples within 10 min and can be used at the point of care (POC).
Thu Nov 02 00:00:00 UTC 2023
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies.
Communications medicine
Kongsuphol P,Jia H,Cheng HL,Gu Y,Shunmuganathan BD,Chen MW,Lim SM,Ng SY,Tambyah PA,Nasir H,Gao X,Tay D,Kim S,Gupta R,Qian X,Kozma MM,Purushotorman K,McBee ME,MacAry PA,Sikes HD,Preiser PR
MA5-29975 was used in Enzyme-linked immunosorbent assay to report a rapid cellulose pull-down viral neutralization test (cpVNT) that detects SARS-CoV-2 NAbs in plasma samples within 10 min and can be used at the point of care (POC).
Thu Nov 02 00:00:00 UTC 2023
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
Viruses
Borrega R,Nelson DKS,Koval AP,Bond NG,Heinrich ML,Rowland MM,Lathigra R,Bush DJ,Aimukanova I,Phinney WN,Koval SA,Hoffmann AR,Smither AR,Bell-Kareem AR,Melnik LI,Genemaras KJ,Chao K,Snarski P,Melton AB,Harrell JE,Smira AA,Elliott DH,Rouelle JA,Sabino-Santos G,Drouin AC,Momoh M,Sandi JD,Goba A,Samuels RJ,Kanneh L,Gbakie M,Branco ZL,Shaffer JG,Schieffelin JS,Robinson JE,Fusco DN,Sabeti PC,Andersen KG,Grant DS,Boisen ML,Branco LM,Garry RF
MA5-29975 was used in Neutralization to demonstrate that, prior to the COVID-19 pandemic, the percentage of Sierra Leonians with cross-reactive antibodies to SARS-CoV-2, MERS-CoV, and seasonal coronaviruses was higher than in United States blood donors.
Sun Nov 21 00:00:00 UTC 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
Viruses
Borrega R,Nelson DKS,Koval AP,Bond NG,Heinrich ML,Rowland MM,Lathigra R,Bush DJ,Aimukanova I,Phinney WN,Koval SA,Hoffmann AR,Smither AR,Bell-Kareem AR,Melnik LI,Genemaras KJ,Chao K,Snarski P,Melton AB,Harrell JE,Smira AA,Elliott DH,Rouelle JA,Sabino-Santos G,Drouin AC,Momoh M,Sandi JD,Goba A,Samuels RJ,Kanneh L,Gbakie M,Branco ZL,Shaffer JG,Schieffelin JS,Robinson JE,Fusco DN,Sabeti PC,Andersen KG,Grant DS,Boisen ML,Branco LM,Garry RF
MA5-29975 was used in Neutralization to demonstrate that, prior to the COVID-19 pandemic, the percentage of Sierra Leonians with cross-reactive antibodies to SARS-CoV-2, MERS-CoV, and seasonal coronaviruses was higher than in United States blood donors.
Sun Nov 21 00:00:00 UTC 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans.
Viruses
Borrega R,Nelson DKS,Koval AP,Bond NG,Heinrich ML,Rowland MM,Lathigra R,Bush DJ,Aimukanova I,Phinney WN,Koval SA,Hoffmann AR,Smither AR,Bell-Kareem AR,Melnik LI,Genemaras KJ,Chao K,Snarski P,Melton AB,Harrell JE,Smira AA,Elliott DH,Rouelle JA,Sabino-Santos G,Drouin AC,Momoh M,Sandi JD,Goba A,Samuels RJ,Kanneh L,Gbakie M,Branco ZL,Shaffer JG,Schieffelin JS,Robinson JE,Fusco DN,Sabeti PC,Andersen KG,Grant DS,Boisen ML,Branco LM,Garry RF
MA5-29975 was used in Neutralization to demonstrate that, prior to the COVID-19 pandemic, the percentage of Sierra Leonians with cross-reactive antibodies to SARS-CoV-2, MERS-CoV, and seasonal coronaviruses was higher than in United States blood donors.
Sun Nov 21 00:00:00 UTC 2021